| Catalog ID | Percent of Cells
with Chromosome | Cytogenetic Description | Additional Information |
| GM09191 | 100 | der(6)t(X;6)(q13p21) (100%) | Line MCP-6; produced by fusing mouse teratocarcinoma line PCC4-1 with human Burkitt lymphoma line G3.32.2; selected in HAT medium; retains 1 hum chromo consistent with der(6)t(X;6)(Xqter>Xq13:: 6p21>6qter) reported by the submitter |
| GM11445 | 100 | der(5)t(5;6)(q33.3;q25.3) (100%) & other human chromosomes | Line HHW1138; human/Chinese hamster somatic cell hybrid; retains human der(5) t(5;6)(q33.3;q25.3) in 100% of cells, #8 in 97% of cells, & #21 in 94% of cells; grown in culture medium containing 0.2mM proline at 39C |
| GM11580 | 100 | | Line PK-89-6A; produced by the fusion of retroviral vector SP-1 infected human lymphoblasts, GM07890, 46,XX,del(13), with CHO cell line UV-135; selected in medium containing histidinol; retains human chromosome #6 in 100% of cells |
| GM13446 | 100 | 6cen>6qter (100%) & other human chromosomes | Line 640-5A; human/Chinese hamster ovary somatic cell hybrid retaining human 6cen>6qter translocated to a rodent chromosome in 100% of cells & #9, #10, & Y; grown in culture medium without selection |
| GM14416 | 96 | der(6)t(6;21)(p25;q11) (96%) & add(3)(p?) (96%) & 12 (96%) & X (92%) | Line R50-3; produced by the fusion of GM00144, 45,XX,-6,-21,+der(6)t(6;21), with pyrimidine auxotrophic CHO line, J405; selected and grown in purine-free medium; retains hum der(6)t(6;21) (96%), add(3)(p?) (96%), #12 (96%), & X (92%) |
| GM14956 | 96 | der(6)t(6;16)(q15;q24.1) (96%), 13 (80%), & 22 (88%) | Line CY100; produced by the fusion of human lymphoblast culture, GM08352, 46,XX,t(6;16)(6pter>6q15::16q24>16qter; 16pter>16q24::6q15>6qter), with APRT deficient mouse A9 cells; retains a human der(6)t(6;16)(q15;q24.1) in 96% of the cells, and a human 13, and 22 |
| GM14969 | 96 | der(16)t(6;16)(p21.3;p13.1) (96%) & 13 (24%) | Line CY185; produced by the fusion of human fibroblast line ZEH, 46,XX,t(6;16) (p21.3;p13.1), with mouse A9 cells; culture grown in medium containing adenine and azaserine; retains human der(16)t(6;16) (p21.3;p13.11) in 96% of cells and 13 (24%) |
| GM15297 | 88 | der(2)t(2;6)(p23;p23) (88%) & other human chromosomes | Produced by the fusion of human fibroblasts, 46,XY,t(2;6)(p23;p23), with A9 mouse cells; culture was grown without selection; retains a human der(2)t(2;6)(p23;p23) in 88% of cells & other human chromosomes |
| GM13448 | 84 | der(6)t(1;6)(q21;q13) (84%), 1 (84%), & other human chromosomes | Line HAL26-12; produced by the fusion of human melanoma cell line, HA, with TK-deficient mouse Cl1D cells; selected in HAT medium; grown without selection; retains human der(6)t(1;6)(q21;q13) in 84% of cells & other human chromosomes |
| GM13445 | 80 | der(7)t(6;7)(q21;q21.2) (80%) & other human chromosomes | Line 5184-4; produced by the fusion of human lymphoblasts, GM05184, 46,XY, t(6;7)(q21;q21.2) with TK-deficient mouse Cl1D cells; selected in HAT medium; retains der(7)t(6;7) in 80% of cells & other human chromosomes |
| GM15301 | 80 | der(7)t(6;7)(q27;p13) (80%) & other human chromosomes | Produced by the fusion of human fibroblasts, 46,XX,t(6;7)(q27;p13), with RAG mouse cells; culture grown without selection; retains a human der(7)t(6;7)(q27;p13) in 80% of cells and other human chromosomes |
| GM15296 | 44 | der(6)t(6;7)(q27;q22) (44%) & other human chromosomes | Line 2068RAG22-2; produced by the fusion of human fibroblast line GM02068, 46,XX,t(6;7)(6pter>6q27::7q22>7qter;7pter>7q22::6q27>6qter), with RAG mouse cells; retains a human der(6)t(6;7)(q27;q22) in 44% of cells and other human chromosomes |